JIVE: AN OPEN-LABEL EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY, EFFICACY, PHARMACODYNAMICS, PHARMACOKINETICS, AND TOLERABILITY OF SUBCUTANEOUS CTI-1601 IN SUBJECTS WITH FRIEDREICH’S ATAXIA

Registry ID

CLIN-1601-201

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

LARIMAR THERAPEUTICS, INC.

Last update

2025-12-23

Conditions

• FRIEDREICH ATAXIA

Related clinical trials

• LONG-TERM OPEN-LABEL STUDY TO ASSESS THE SAFETY AND EFFICACY OF VATIQUINONE IN PATIENTS WITH FRIEDREICH ATAXIA

View on source registry